Merck & Co., Inc. - Net Worth and Insider Trading
Merck & Co., Inc. Net Worth
The estimated net worth of Merck & Co., Inc. is at least $4.3 Billion dollars as of 2025-05-16. Merck & Co., Inc. is the 2201 Interest of corporation controlled by you of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd and owns about 13,443,693 shares of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) stock worth over $4.3 Billion. Details can be seen in Merck & Co., Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Merck & Co., Inc. has not made any transactions after 2025-04-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Merck & Co., Inc.
Merck & Co., Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Merck & Co., Inc. owns 1 companies in total, including Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) .
Click here to see the complete history of Merck & Co., Inc.’s form 4 insider trades.
Insider Ownership Summary of Merck & Co., Inc.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06990 | Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | 2025-04-30 | 2201 Interest of corporation controlled by you |
Merck & Co., Inc. Latest Holdings Summary
Merck & Co., Inc. currently owns a total of 1 stock. Merck & Co., Inc. owns 13,443,693 shares of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) as of April 25, 2025, with a value of $4.3 Billion.
Latest Holdings of Merck & Co., Inc.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06990 | Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | 2025-04-25 | 13,443,693 | 321.20 | 4,318,114,192 |
Holding Weightings of Merck & Co., Inc.
Merck & Co., Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Merck & Co., Inc. has made a total of 3 transactions in Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is the sale of 0 shares on April 25, 2025, which brought Merck & Co., Inc. around $0.
Insider Trading History of Merck & Co., Inc.
- 1
Merck & Co., Inc. Trading Performance
Merck & Co., Inc. Ownership Network
Ownership Network List of Merck & Co., Inc.
Ownership Network Relation of Merck & Co., Inc.
Merck & Co., Inc. Owned Company Details
What does Sichuan Kelun-Biotech Biopharmaceutical Co Ltd do?
Who are the key executives at Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?
Merck & Co., Inc. is the 2201 Interest of corporation controlled by you of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd. Other key executives at Sichuan Kelun-Biotech Biopharmaceutical Co Ltd include 2101 Beneficial owner Merck Sharp & Dohme LLC , 2201 Interest of corporation controlled by you LIU Gexin , and 2201 Interest of corporation controlled by you si chuan ke lun yao ye gu fen you xian gong si .
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) Insider Trades Summary
Over the past 18 months, Merck & Co., Inc. made 1 insider transaction in Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) with a net sale of 0. Other recent insider transactions involving Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) include a net purchase of 785,000 shares made by LIU Gexin , a net purchase of 785,000 shares made by si chuan ke lun yao ye gu fen you xian gong si , and a net sale of 0 shares made by cheng du ke lun jing chuan ke ji you xian gong si .
In summary, during the past 3 months, insiders sold 0 shares of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990) were sold and 1,570,000 shares were bought by its insiders, resulting in a net purchase of 1,570,000 shares.
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd (HKSE:06990)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd Insider Transactions
Merck & Co., Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Merck & Co., Inc.. Currently GuruFocus does not have mailing address information for Merck & Co., Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
